Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.88%
624.65
+5.44
+0.88%
—619.21618.96625.29615.58——
SX6P
Utilities
SX6P
Utilities
SX6P
+1.47%
538.67
+7.81
+1.47%
—530.86530.03539.70526.25——
SX8P
Technology
SX8P
Technology
SX8P
+0.59%
936.07
+5.45
+0.59%
—930.62924.86942.94921.75——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-0.07%
455.72
-0.33
-0.07%
—456.05452.80456.46446.45——
SXDP
Health Care
SXDP
Health Care
SXDP
+0.07%
1,091.34
+0.71
+0.07%
—1,090.631,086.801,095.221,078.00——
SXEP
Energy
SXEP
Energy
SXEP
+1.37%
542.67
+7.33
+1.37%
—535.34536.16545.74536.16——
SXFP
Financials
SXFP
Financials
SXFP
+1.38%
902.55
+12.32
+1.38%
—890.23887.34902.55883.68——
SXKP
Communications
SXKP
Communications
SXKP
+1.44%
317.29
+4.51
+1.44%
—312.78311.95319.44310.80——
SXNP
Industrials
SXNP
Industrials
SXNP
+0.94%
1,105.94
+10.34
+0.94%
—1,095.601,090.801,109.451,082.31——
SXPP
Materials
SXPP
Materials
SXPP
+0.13%
819.13
+1.06
+0.13%
—818.07813.89826.30804.46——
002422:SHE
Sichuan Kelun Pharmaceutical Co Ltd
CNÂ¥30.63
-2.39%
(-0.75) 1D
May 18, 3:04:30 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002422...
Open
CNÂ¥31.39
High
CNÂ¥31.39
Low
CNÂ¥30.30
Mkt. cap
49.92B
Avg. vol.
19.04M
Volume
15.85M
Dividend
1.94%
Quarterly dividend
CNÂ¥0.15
Ex dividend date
May 11, 2026
P/E ratio
30.78
52-wk high
CNÂ¥41.72
52-wk low
CNÂ¥28.14
EPS
CNÂ¥1.00
Shares outstanding
1.59B
No. of employees
20K
News stories
From sources across the web
About Sichuan Kelun Pharmaceutical Co Ltd
CEO-
Employees20.1K
Founded1996
Headquarters-
SectorPharmaceutical industry
Websitekelun.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.69B
4.19B
5.24B
4.26B
Cost of goods sold
2.38B
2.29B
2.85B
2.33B
Cost of revenue
2.38B
2.29B
2.85B
2.33B
Research and development expenses
564.04M
584.41M
572.64M
586.14M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.12B
1.03B
1.17B
992.40M
Operating expense
1.71B
1.51B
1.97B
1.66B
Total operating expenses
4.09B
3.80B
4.82B
3.99B
Operating income
603.47M
390.58M
416.66M
271.42M
Other non operating income
6.36M
-139.75M
146.54M
82.48M
EBT including unusual items
644.46M
231.28M
754.91M
441.05M
EBT excluding unusual items
665.20M
292.43M
562.20M
407.20M
Income tax expense
190.20M
100.37M
122.46M
-31.65M
Effective tax rate
29.51%
43.40%
16.22%
-7.18%
Other operating expenses
6.43M
-103.78M
233.64M
66.32M
Net income
416.38M
200.04M
501.27M
453.70M
Net profit margin
8.87%
4.77%
9.57%
10.65%
Earnings per share
-
-
-
-
Interest and investment income
81.94M
72.25M
63.65M
76.41M
Interest expense
-27.23M
-29.99M
-19.09M
-23.12M
Net interest expenses
54.71M
42.26M
44.56M
53.29M
Depreciation and amortization charges
-
-
-
-
EBITDA
925.53M
691.68M
739.75M
594.51M
Gain or loss from assets sale
-3.30M
3.30M
-5.32M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer